Global Corporate Affairs Archives | Page 148 of 1087 | Be Korea-savvy

Archive by category Global Corporate Affairs

The UK, the Netherlands, Egypt and Saudi Arabia among likely winners in the changing world order

The UK, the Netherlands, Egypt and Saudi Arabia among likely winners in the changing world order

TMF Group today launched its 12th annual study on global business complexity, ranking countries according to the burden of their rules for doing business. LONDON, May 28, 2025 (Korea Bizwire) — The Global Business Complexity Index (GBCI) studies over 250 indicators of complexity in 79 jurisdictions that represent 94% of the world’s GDP. The complexity that the [...]

Ascom launches share buyback program

Ascom launches share buyback program

Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, May 28, 2025 Ascom Holding AG will start its previously announced share buyback program on 30 May 2025. Ascom mandated Zürcher Kantonalbank to repurchase up to a maximum of 3 million registered shares on the second trading line on SIX Swiss Exchange and up to [...]

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to bringing important new treatment options to underserved patient populations TEL AVIV, Israel, May 27, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries, Ltd. [...]

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June

TEL AVIV, Israel, May 27, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies Global Healthcare Conference Chris Fox, EVP U.S. Commercial and Dr. Eric Hughes, EVP Global R&D and Chief Medical [...]

Mavenir’s Converged Packet Core Solution Set to Transform Tampnet’s Global 4G/5G Mobile Network

Mavenir’s Converged Packet Core Solution Set to Transform Tampnet’s Global 4G/5G Mobile Network

New partnership empowers offshore connectivity innovator to deliver cloud-native 5G services – including enhanced mobile broadband, URLLC and mMTC READING, United Kingdom, May 27, 2025 (Korea Bizwire) – Mavenir, the cloud-native network infrastructure provider, today announced that it has been selected as a key technology partner by Tampnet – a global leader in offshore, high-capacity, [...]

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA). The RENASYS TOUCH NPWT System demonstrated clinical efficacy,1,2,3,4 and operational fitness [...]

Hivello x Banxa – $HVLO Token Available via Apple Pay & Credit Card

Hivello x Banxa – $HVLO Token Available via Apple Pay & Credit Card

LONDON and AMSTERDAM, May 27, 2025 (Korea Bizwire) – Hivello, a DePIN aggregator that enables users to earn by monetizing idle (computing) resources across multiple DePINs (Decentralized Physical Infrastructure Networks), announces that its native token $HVLO will soon be integrated with Banxa, a global fiat-to-crypto on-ramp solution trusted by leading Web3 platforms. This integration means that [...]

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. (Image from Teva webpage) BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed [...]

Junshi Biosciences Announces Ongericimab’s sNDA Approval in China

Junshi Biosciences Announces Ongericimab’s sNDA Approval in China

SHANGHAI, May 27, 2025 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (the “NMPA”) has approved two supplemental new drug applications for the ongericimab injection (a recombinant [...]

Bitget Expands into Real-World Assets with BGUSD, Offering Daily Yields and High Liquidity

Bitget Expands into Real-World Assets with BGUSD, Offering Daily Yields and High Liquidity

VICTORIA, Seychelles, May 27, 2025 (Korea Bizwire) – Bitget, the leading cryptocurrency exchange and Web3 company, has announced the launch of BGUSD, a yield-bearing stable asset certificate designed to enhance capital efficiency and provide passive income opportunities for users worldwide. BGUSD is fully integrated into the platform’s trading and wealth management infrastructure, offering a multifaceted utility [...]